Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris
D Mango, S Ricci, P Manna, GAD Miggiano, GB Serra - Contraception, 1996 - Elsevier
The effect of gestodene 75 μg (GTD) versus desogestrel 150 μg (DSG) combined with 30 μg
of ethinylestradiol (EE) on acne lesions and plasma androstenedione (A), total testosterone …
of ethinylestradiol (EE) on acne lesions and plasma androstenedione (A), total testosterone …
A quantitative biometrological assessment of acne and hormonal evaluation in young women using a triphasic low-dose oral contraceptive containing gestodene
C Piérard-Franchimont, U Gaspard… - … European Journal of …, 2000 - Taylor & Francis
Objective To investigate the effect of a triphasic low-dose oral contraceptive pill containing
gestodene on acne severity and hormone levels in young women over 13 menstrual cycles …
gestodene on acne severity and hormone levels in young women over 13 menstrual cycles …
Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational …
C Di Carlo, V Gargano, S Sparice… - Gynecological …, 2013 - Taylor & Francis
This study shows the effect of a 1 year treatment with an estradiol valerate/dienogest pill in
36 women suffering from polycystic ovaries and mild or moderate acne. At beginning of the …
36 women suffering from polycystic ovaries and mild or moderate acne. At beginning of the …
Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate
M Vartiainen, H De Gezelle… - The European Journal of …, 2001 - Taylor & Francis
Objective: To investigate the effect of a combiphasic oral contraceptive containing
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
ethinylestradiol and desogestrel (combiphasic EE/DSG) on acne, compared with a …
Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d, l-norgestrel
A LEMAY, SD DEWAILLY, R GRENIER… - The Journal of Clinical …, 1990 - academic.oup.com
The effect of a low dose triphasic oral contraceptive (OC) was evaluated during a 6-month
treatment period in 41 patients (mean age, 25.4±0.7 yr) who had grade I-IV postpubertal …
treatment period in 41 patients (mean age, 25.4±0.7 yr) who had grade I-IV postpubertal …
Evaluation of hormonal factors in acne vulgaris and the course of acne vulgaris treatment with contraceptive-based therapies in young adult women
D Borzyszkowska, M Niedzielska, M Kozłowski… - Cells, 2022 - mdpi.com
Acne vulgaris is a common chronic inflammatory skin disease, which is considered one of
the diseases of civilization due to the significant influence of environmental factors on the …
the diseases of civilization due to the significant influence of environmental factors on the …
[PDF][PDF] Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate
C Charoenvisal, Y Thaipisuttikul, S Pinjaroen… - 1996 - repository.ubn.ru.nl
Objective—To compare the effects of a low-dose oral contraceptive containing desogestrel
(Marvelon) and an anti-androgenic preparation containing cyproterone acetate (Diane) in …
(Marvelon) and an anti-androgenic preparation containing cyproterone acetate (Diane) in …
A randomized controlled trial of second-versus third-generation oral contraceptives in the treatment of acne vulgaris
MP Rosen, DM Breitkopf, M Nagamani - American journal of obstetrics and …, 2003 - Elsevier
Objective: This study was undertaken to compare the clinical efficacy of second-versus third-
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …
generation oral contraceptives in the treatment of acne. Study Design: Thirty-four women …
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel
A Volpe, M Silferi, A Mauri, P Deiana, S Angioni… - European Journal of …, 1994 - Elsevier
A new biphasic oral contraceptive (OC) containing ethinylestradiol and desogestrel (DGS) in
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …
both phases of the cycle (7 days 40 25 μg+ 15 days 30 125 μg) was tested for its reliability …
[HTML][HTML] A randomized, controlled trial of a low-dose contraceptive containing 20 μg of ethinyl estradiol and 100 μg of levonorgestrel for acne treatment
D Thiboutot, DF Archer, A Lemay, K Washenik… - Fertility and sterility, 2001 - Elsevier
Objective: To evaluate the efficacy of a low-dose oral contraceptive (OC) containing 100 μg
of levonorgestrel (LNG) and 20 μg of ethinyl estradiol (EE) compared with placebo for the …
of levonorgestrel (LNG) and 20 μg of ethinyl estradiol (EE) compared with placebo for the …